Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00283179
Recruitment Status : Completed
First Posted : January 27, 2006
Last Update Posted : May 15, 2008
Information provided by:
Taiwan Otsuka Pharm. Co., Ltd

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : December 2004